Results 201 to 210 of about 568,486 (233)

OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema: A Prospective Study.

Ophthalmology (Rochester, Minn.), 2019
PURPOSE To prospectively determine the relationship of OCT angiography (OCTA) metrics to diabetic retinopathy (DR) progression and development of diabetic macular edema (DME). DESIGN Prospective, observational study.
Zi-Han Sun, Fang-Yao Tang, R. Wong, Jerry K. H. Lok, Simon K. H. Szeto, Jason C. K. Chan, Carmen K. M. Chan, C. Tham, D. Ng, C. Cheung   +9 more
semanticscholar   +1 more source

Photocoagulation for Diabetic Macular Edema

Archives of Ophthalmology, 1986
To the Editor. —The Early Treatment Diabetic Retinopathy Study Research Group (ETDRS) should be complimented for their efforts in carrying out the randomized clinical trial designed to evaluate photocoagulation and aspirin treatment in the management of patients with nonproliferative diabetic retinopathy.
openaire   +2 more sources

Pathophysiology of Diabetic Macular Edema

2007
Diabetic maculopathy is the leading cause of visual loss in diabetic patients. The pathogenesis is not fully understood and a satisfactory therapy is currently not available. Malfunction of the blood-retinal barrier plays a central role in the disease and leads to retinal edema and secondary photoreceptor dysfunction.
Antonia M, Joussen, Neil, Smyth, Carien, Niessen   +2 more
openaire   +2 more sources

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Yearbook of Ophthalmology, 2016
The members of the writing committee (John A. Wells, M.D., Palmetto Retina Center, West Columbia, SC; Adam R. Glassman, M.S., Jaeb Center for Health Research, Tampa, FL; Allison R. Ayala, M.S., Jaeb Center for Health Research, Tampa, FL; Lee M. Jampol, M.
O. Gupta
semanticscholar   +1 more source

Risuteganib—a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema

Expert Opinion on Investigational Drugs, 2020
Introduction Non-exudative (dry) age-related macular degeneration (AMD) and diabetic macular edema (DME) are leading causes of vision loss worldwide.
Lincoln T. Shaw, Anna G. Mackin, Reanna Shah, Siona Jain, Prisha Jain, R. Nayak, S. Hariprasad   +6 more
semanticscholar   +1 more source

DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study

Retina, 2019
Purpose: To investigate efficacy and safety of repeated dexamethasone (DEX) implants over 24 months, in diabetic macular edema (DME) eyes that were treatment naive compared with eyes refractory to anti-vascular endothelial growth factor treatment, in a ...
Matias Iglicki, C. Busch, D. Zur, Mali Okada, Miriana Mariussi, J. Chhablani, Z. Cebeci, S. Fraser-bell, V. Chaikitmongkol, A. Couturier, E. Giancipoli, M. Lupidi, Patricio J. Rodríguez-Valdés, M. Rehak, Adrian T. Fung, M. Goldstein, A. Loewenstein   +16 more
semanticscholar   +1 more source

The Role of Steroids in the Management of Diabetic Macular Edema

Ophthalmic Research, 2019
Inflammation is substantially contributing to the development and worsening of diabetic retinopathy in general and diabetic macular edema (DME) in particular, which provides the rationale to treat DME with corticosteroids. While anti-vascular endothelial
D. Zur, Matias Iglicki, A. Loewenstein
semanticscholar   +1 more source

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Ophthalmology (Rochester, Minn.), 2003
C. P. Wilkinson, Frederick L. Ferris, Ronald Klein, Paul P. Lee, C. Agardh, M. Davis, D. Dills, A. Kampik, R. Pararajasegaram, Juan T. Verdaguer   +9 more
semanticscholar   +1 more source

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

Ophthalmology (Rochester, Minn.), 2012
Q. Nguyen, David M. Brown, Dennis M. Marcus, David S. Boyer, Sunil S. Patel, L. Feiner, Andrea Gibson, J. P. Sy, A. C. Rundle, J. Hopkins, Roman G. Rubio, J. S. Ehrlich   +11 more
semanticscholar   +1 more source

Diabetic Macular Edema

2002
Diabetic retinopathy remains one of the four major causes of blindness in the western world [1], [2]. Blindness from diabetic retinopathy results from consequences of proliferative diabetic retinopathy and from diabetic macular edema. Proliferative diabetic retinopathy is more likely than macular edema to cause rapid and severe loss of vision.
openaire   +1 more source